Abstract
INTRODUCTION
Excessive extracellular matrix (ECM) of the liver results in cirrhosis, which is an end stage liver disease with high mortality and for which efficacious medical treat ments are not currently available, except for liver tran splantation. Hepatic stellate cell (HSC) activation is considered a major mechanism in the formation of fibrosis and cirrhosis. However, fundamental questions concerning the cell fate regulation of HSCs remain largely underexplored. A recent study reported that hepatic mesothelial cells are the potential precursors for HSCs in the development of liver disease and can transdifferentiate into myofibroblast cells in mouse liver fibrosis [13] . Until now, there have been few specific mouse lines that cause recombination (Cre recombinase, Cre) for tracing hepatic mesothelial cells or HSCs. The Wt1
CreERT2 mice are useful to trace hepatic mesothelial cells, but the labeling efficiency and specificity is low [46] . Specific genes have been identified in hepatic mesothelial cells and HSCs by microarray [7, 8] . We plan to develop Cre mouse lines with specific markers for the study of HSCs or hepatic mesothelial cells. Based on a previous study, glycoprotein M6a (Gpm6a) has been identified as a specific surface marker of hepatic mesothelial cells. It covers the surface of the liver and migrates from the surface into the center [4] . Reelin is an extracellular matrix glycoprotein, which is a specific HSC marker in the mouse liver and has similar amounts in resting and activated HSCs [9] .
The Gpm6a
GFPCreERT2 or Reelin GFPCreERT2 mouse line will express a fusion protein of green fluorescent protein (GFP), Cre, and estrogen receptor induced by tamoxifen (ERT2) under the control of the Gpm6a or Reelin promoter. GFP is used to track the labeled protein as a marker. Cre recombinase is used to delete a segment of DNA flanked by LoxP sites (flox). The ERT2 system is used to activate Cre activity by tamoxifen treatment [10, 11] . Cre mouse lines are very useful tools that can generate knockout mice through the cross breeding of Cre and flox mouse lines. A mouse line is needed to trace HSC lineages and study their function through the knockout of specific genes in specific cells. It is, therefore, necessary to prepare a Gpm6a
GFPCreERT2 or Reelin GFPCreERT2 mouse line. In this study, we investigated the preparation and identification of a Gpm6a/ Reelin GFPCreERT2 construct, which is the first step for the preparation of a Gpm6a GFPCreERT2 or Reelin GFPCreERT2 mouse line. 
MATERIALS AND METHODS

Removal of the Kam unit and selection of the deleted Kam clone
SW105 E. coli (NCI) was streaked without antibiotics. A single colony was picked and competent cells were made. Recombinant BAC DNA was transformed into competent cells with electroporation and inoculated in LB medium with Larabinose (Sigma) for removal of the Kam unit. They were then plated onto LB plates with Cmr only. We confirmed that no colonies were on the LB plate with Cmr and Kam. Sixteen colonies were picked and checked by PCR using the 5arm primer (Table 1) . One colony was confirmed by PCR using different primers ( Table 1 ). The PCR product was digested with BamHI and AflII (New England Biolabs) for further confirmation.
RESULTS
Conformation of BAC by restriction enzyme BamHI digestion
As mentioned previously, we purchased BAC from BPRC and confirmed the BAC sequence. From Figure  1 , it can be observed that, after digestion with BamHI, Gpm6a BAC had 11 bands, which was the expected pattern. For Reelin BAC, the same results were obtained. Therefore, we confirmed that we received the BAC clone.
Confirmation of BAC DNA transformed into SW102 E. coli
BAC DNA is so long that it is impossible to transform BAC into SW102 E. coli by chemical transduction [12] . We transformed purified BAC into SW102 E. coli by electroporation. After electroporation, we purified BAC from SW102 E. coli and identified BAC with restriction enzyme BamHI digestion. For Gpm6a BAC, after BamHI digestion, selected clones did not show the same digestion pattern with original BAC, as shown in Figure 2 , which suggested the original BAC DNA may have been fragmented during the purification step. For Reelin BAC, we obtained two positive clones that showed the same pattern as the original BAC after BamHI digestion. We improved the purification methods, and we finally succeeded in trans forming the complete Gpm6a BAC into SW102 E. coli competent cells and transformed the fragment of GFPCreERT2 into the SW102 E. coli carrying the BAC. After homologous recombination between BAC and GFPCreERT2, GFPCreERT2 replaced the first exon in the BAC vector. Then, we purified the recombinant BAC for screening and confirmation. As shown in Figure 4B , we obtained 14 positive clones for Gpm6a (14/25, 56%), as evidenced by PCR screening. For Reelin, we obtained 22 positive clones (22/25, 88%). We further confirmed the positive clones by restriction enzyme digestion. For Gpm6a, we found that the band change was the same as the expected pattern after BamHI or KpnI digestion ( Figure 4C ). Reelin had the same results ( Figure 4D ). The results suggested that GFPCreERT2 was inserted into the correct site in the BAC vector and that we acquired the recombinant BAC.
( Figure 2B ).
Preparation of the reporter gene GFPCreERT2
The reporter gene GFPCreERT2 was in the shuttle vector that contained some genes encoding the 5arm, flp recombinase target (FRT), Kam, FRT, GFPCreERT2, 3arm and ampicillin. We used NotI and FseI to digest the shuttle vector and obtained the fragment of GFPCreERT2 flanked by the 5arm and 3arm. As shown in Figure 3 , after digestion with NotI and FseI, we obtained two bands; one was approximately 7600 bp, and the other was approximately 2800 bp. We recovered the long band containing GFPCreERT2 from the agarose gels for transformation.
Screening and confirmation of recombinant clones
We induced the SW102 E. coli carrying BAC to become 
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Screening and confirmation of recombinant clones without the Kam gene
Finally, we removed the Kam unit that could interfere with the expression of the reporter gene. We purified the recombinant BAC carrying GFPCreERT2 and transformed it into SW105 E. coli. The Kam unit was removed by homologous recombination. As shown in Figure 5B , we obtained 16 positive clones for Gpm6a (16/16, 100%), as evidenced by PCR screening. We further confirmed the positive clones by PCR with different primers. We obtained different sizes of bands that were consistent with what was expected ( Figure  5C ). We digested the PCR product of 4527 bp with BamHI or AflII, and the bands obtained were the same as expected ( Figure 5D ). This suggested that the Kam unit was removed and that we obtained BAC carrying GFPCreERT2 without Kam.
DISCUSSION
First of all, we needed to choose a vector to prepare the Gpm6a/Reelin GFPCreERT2 construct. As a conventional vector, its advantage was that it is easy to handle, but it had low expression levels of the reporter genes and low specificity because the DNA size is approximately 35 kb and contains only a promoter. For the BAC vector, its advantages include relatively high efficiency and relatively high specificity, but BAC DNA is fragile and can break easily because BAC DNA is approximately 200 kb and contains all the regulatory sequences upstream and downstream of the encoding sequence [13, 14] . Thus, we chose a BAC vector to prepare the constructs of Gpm6a GFPCreERT2 and Reelin
GFPCreERT2
. Second, how to insert reporter genes into BAC DNA was a question. In 200 kb of BAC DNA, there would be 49 recognition sites for 6 nucleotide cutters such as EcoRI and BamHI, so it was impossible to use restriction enzyme digestion and ligation. We, therefore, used homologous DNA recombination for gene insertion [1518] . In BAC DNA, we designed the primers upstream or downstream of the first exon and obtained the 5arm and 3arm fragment by PCR amplification. In the shuttle vector, the 5arm fragment was inserted upstream of the reporter gene, and the 3arm fragment was inserted downstream of the reporter gene. In SW102 E. coli, the reporter gene that is GFPCreERT2 replaced the first exon in the BAC vector by homologous recombination. The expression of GFPCreERT2 is regulated by the Gpm6a or Reelin promoter.
Finally, we removed the Kam unit by homologous recombination of the FRT using SW105 E. coli. The FRT is similar to LoxP, which is used to delete a segment of DNA flanked by LoxP sites [19] . The FRT cassette was excised with high frequency, which was close to 100% [20] . Then, we obtained the constructs of
Gpm6a
GFPCreERT2 and Reelin GFPCreERT2 successfully. After microinjection, we can develop the mouse line with Gpm6a GFPCreERT2 and Reelin
GFPCreERT2
. Homologous recombination was performed with modified E. coli bacteria strains: SW102 and SW105. SW102 E. coli carries genes such as exo, bet and gam. Exo encodes 5'3' exonuclease, and bet encodes the overhang binding protein, which enables annealing and recombination with complementary DNA; gam encodes the inhibitor of E. coli exonuclease to protect the introduced DNA. SW105 E. coli carries the Larabinose inducible flp gene, which encodes recombinase, allowing DNA modification without restriction enzymes and DNA ligase [21] . CreLox recombination is a sitespecific recom binase technology that is widely used to carry out deletions, insertions, translocations and inversions in the DNA of cells. It allows the DNA modification to be targeted to a specific cell type or to be triggered by a specific external stimulus [22, 23] . For a mouse line with Gpm6a
GFPCreERT2 and Reelin
, once the specific genes, such as Gpm6a or Reelin, begin to express, the GFPCreERT2 will express in the specific cell. Using GFP as a marker, we can trace the specific cells. Using the CreERT2 system, we can knock out the specific gene in specific cells, which is a conditional knockout [24] . In the next stage, we will label hepatic mesothelial and HSCs in the Gpm6a/Reelin GFPCreERT2 transgenic mouse to trace the lineage of HSCs. We will also make a conditional TGFβknockout mouse through cross breeding of the TGF flox/flox mouse and the Gpm6a/ Reelin GFPCreERT2 mouse to explore the function of HSCs 
COMMENTS
Background
Hepatic stellate cell (HSC) activation is considered a major mechanism in the formation of fibrosis and cirrhosis. However, fundamental questions concerning the cell fate regulation of HSCs remain largely underexplored. A recent study reported that hepatic mesothelial cells are the potential precursors of HSCs in the development of the liver and can transdifferentiate into myofibroblast cells in mouse liver fibrosis. Until now, there have been few specific mouse lines that could cause recombination (Cre) for tracing hepatic mesothelial cells or HSCs.
Here, we describe a rapid and reliable strategy for construct preparation using the bacterial artificial chromosome (BAC).
Research frontiers
A recent study reported that hepatic mesothelial cells are the potential precursors for HSCs in the development of the liver and can transdifferentiate into myofibroblast cells in mouse liver fibrosis. Glycoprotein M6a (Gpm6a) has been identified as a specific surface marker of hepatic mesothelial cells, which cover the surface of the liver and migrate from the surface into the center.
Reelin is an extracellular matrix glycoprotein, which is a specific HSC marker in the mouse liver and has similar amounts in resting and activated HSCs.
Innovations and breakthroughs
Until now, there have been few specific mouse lines that could Cre for tracing hepatic mesothelial cells or HSCs. Here, the authors describe a rapid and reliable strategy for construct preparation using a BAC. This study prepared a Gpm6a/Reelin GFPCreERT2 construct for the first time, which is the first step in the preparation of a Gpm6a
GFPCreERT2 or Reelin GFPCreERT2 mouse line.
Applications
In this study, a construct of Gpm6a GFPCreERT2 or Reelin GFPCreERT2 was prepared successfully, which will establish the foundation for tracing the HSC lineage and studying its function.
Terminology
Cre-Lox recombination is a site-specific recombinase technology widely used to create deletions, insertions, translocations and inversions in the DNA of cells. It allows the DNA modification to be targeted to a specific cell type or 
